(Date:11/30/2009)...ewswire/ -- The Michael J. Fox Foundation for Park...on in total awards to six research teams working t...for Parkinson,s disease. The funding was awarded u...arkinson,s Disease program, made possible by fund...euroscience-based biotechnology company. ,, Th...
(Date:11/30/2009).... Jessica Torrente, Assistant Professor of Radiolo...in Washington, D.C., demonstrated the integration ... clinical practice as an adjunct imaging modality ...nual meeting of the Radiological Society of North ...was to demonstrate how BSGI is used in the clinica...
(Date:11/30/2009)...viding smart and efficient software to the preclin...volutionizing work-from-home histopathology by uti...re used by 8 of the Top 10 Pharmaceutical Companie...uo; basis. , Mount Arling...nced another evolution in the histopathology realm...
(Date:11/30/2009)...PRNewswire/ -- ApaTech, the rapidly growing,orthob...ng,Biotech/Pharmaceutical/Medical Technology/Equip...500 for EMEA (Europe, Middle East and Africa). ,...s, five-year revenue growth,for which ApaTech has...achievement places ApaTech 9th overall in the rank...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4... Corporation,(Nasdaq: BPUR ) today announced that... Healthcare Products Regulatory Agency (MHRA) is s... of the meeting is to clarify the issues outlined ...e United Kingdom,s Commission,on Human Medicines r...uthorization for Hemopure(R). The issues relate to...
...red Hutchinson Cancer,Research Center have a lead ... the first systematic surveillance program of men ...to help determine when to wait and when,to treat t...y Foundation,and the National Cancer Institute., ...nical Research and,Human Biology divisions, will l...
...mployees were recognized,for their significant con...nnual TWIN Awards Dinner held May 1, 2008. Honored...ncology, Drug Regulatory Affairs, and Sherrie,Piet...mistry., "These individuals exemplify the best an...ontributions to the company,s success, and to the ...
Other Biology Technology:Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 2Biopure Announces Date to Meet with UK's Medicines and Healthcare Products Agency 3When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 2When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer 3Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 2Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees 3Phosphate Colorimetric Assay Kit, PiBlue from BioAssay Systems
Phosphate Colorimetric Assay Kit from BioAssay Systems
Varian 1200L GC/MS from Varian, Inc.
EnzChek cellulase substrate *blue fluorescent, 339/452 from Invitrogen
Biology Products: